Glenmark Life Sciences Limited (GLS.BO)
INR 1021.7
(-0.42%)
INR 1021.7
(-0.42%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.13 Billion | 3.13 Billion | 5.97 Billion | 3.88 Billion | 1.95 Billion | 103.52 Million |
| Net Income | 6.31 Billion | 6.28 Billion | 5.64 Billion | 4.7 Billion | 4.21 Billion | 2.28 Billion |
| Depreciation & Amortization | 534.52 Million | 420.94 Million | 378.77 Million | 333.94 Million | 293.68 Million | 192.62 Million |
| Deferred income taxes | - | -1.48 Billion | -1.29 Billion | - | - | - |
| Stock-based compensation | 43.75 Million | 31.85 Million | 34.98 Million | - | - | - |
| Change in working capital | -1.34 Billion | -1.96 Billion | 998.4 Million | -1.07 Billion | -1.9 Billion | -932.56 Million |
| Other non-cash items | -104.75 Million | -152.19 Million | 211.81 Million | -86.48 Million | -651.65 Million | -1.43 Billion |
| Investing Cash Flow | -1.16 Billion | -1.54 Billion | -1.22 Billion | -687.34 Million | -505.18 Million | -89.14 Million |
| Investments in PPE | -1.28 Billion | -1.7 Billion | -1.32 Billion | -679.93 Million | -511.66 Million | -93.25 Million |
| Acquisitions | 4.65 Million | 1.74 Million | 4.69 Million | 16.34 Million | 2.93 Million | - |
| Investment purchases | - | - | - | -28.05 Million | - | - |
| Sales/Maturities of investments | - | 1.11 Million | 28.05 Million | 32.35 Million | - | - |
| Other Investing Activities | 124.86 Million | 157.66 Million | 66.7 Million | -28.05 Million | 3.55 Million | 4.11 Million |
| Financing Cash Flow | -2.79 Billion | -3.87 Billion | -787.96 Million | -2.13 Billion | -1.36 Billion | 5.35 Million |
| Debt repayment | -22.09 Million | -16.43 Million | -9.6 Billion | -2.13 Billion | -1.36 Billion | -9.65 Million |
| Dividends payments | -2.75 Billion | -3.85 Billion | -1.28 Billion | - | - | - |
| Common Stock Repurchased | - | - | 9.31 Billion | - | - | - |
| Common Stock Issuance | - | - | 10.11 Billion | - | - | 15 Million |
| Other Financing Activities | -15.46 Million | -16.75 Million | -9.32 Billion | -2.13 Billion | -1.36 Billion | 5.35 Million |
| Accounts receivables | 378.6 Million | -1.33 Billion | -592.15 Million | -410.2 Million | -1.97 Billion | -930.52 Million |
| Accounts payables | -341.21 Million | 981.77 Million | 737.49 Million | 340.89 Million | 193.02 Million | -590.17 Million |
| Inventory | -826.26 Million | -879.27 Million | -28.23 Million | -1 Billion | -119.32 Million | 588.13 Million |
| Other working capital | -551.93 Million | -735.63 Million | 881.29 Million | -491.21 Million | -195.24 Million | -72.35 Million |
| Cash at beginning of period | 2.83 Billion | 5.12 Billion | 1.15 Billion | 99.98 Million | 20.61 Million | 70 Thousand |
| Cash at end of period | 3.01 Billion | 2.83 Billion | 5.12 Billion | 1.15 Billion | 99.98 Million | 20.61 Million |
| Capital Expenditure | -1.28 Billion | -1.7 Billion | -1.32 Billion | -679.93 Million | -511.66 Million | -93.25 Million |
| Effect of forex changes on cash | - | - | - | - | - | 810 Thousand |
| Net cash flow / Change in cash | 175.91 Million | -2.28 Billion | 3.96 Billion | 1.05 Billion | 79.37 Million | 20.54 Million |
| Free Cash Flow | 2.84 Billion | 1.43 Billion | 4.65 Billion | 3.2 Billion | 1.43 Billion | 10.27 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.11 Billion | 979.37 Million | 6.31 Billion | 1.18 Billion | 1.18 Billion | 1.35 Billion |
| Depreciation & Amortization | - | - | 534.52 Million | 131.77 Million | 131.28 Million | 126.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 43.75 Million | 43.75 Million | - | - | - |
| Change in working capital | - | - | -1.34 Billion | - | - | - |
| Other non-cash items | -1.11 Billion | -979.37 Million | -104.75 Million | -1.18 Billion | -1.18 Billion | -1.35 Billion |
| Investing Cash Flow | - | - | -1.16 Billion | - | - | - |
| Investments in PPE | - | - | -1.28 Billion | - | - | - |
| Acquisitions | - | - | 4.65 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 124.86 Million | - | - | - |
| Financing Cash Flow | - | - | -2.79 Billion | - | - | - |
| Debt repayment | - | - | -22.09 Million | - | - | - |
| Dividends payments | - | - | -2.75 Billion | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -15.46 Million | - | - | - |
| Accounts receivables | - | - | 378.6 Million | - | - | - |
| Accounts payables | - | - | -341.21 Million | - | - | - |
| Inventory | - | - | -826.26 Million | - | - | - |
| Other working capital | - | - | -551.93 Million | - | - | - |
| Cash at beginning of period | - | - | 2.83 Billion | 4.43 Billion | 3.24 Billion | 3.09 Billion |
| Cash at end of period | - | - | 3.01 Billion | 1.18 Billion | 4.43 Billion | 1.35 Billion |
| Capital Expenditure | - | - | -1.28 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 175.91 Million | -3.24 Billion | 1.18 Billion | -1.73 Billion |
| Free Cash Flow | - | - | 2.84 Billion | 1.18 Billion | 1.18 Billion | 1.35 Billion |
MTSA4
NOXL
TRAIN-B
MX1
ALFVY
PAYC